Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/08/20 → 3/08/21 |
Funding
- UK-based charities: £51,374.00
SPIKE-1 TRIAL: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
- Dhaliwal, Kevin (Principal Investigator)
- Akram, Ahsan (Co-investigator)
- Norrie, John (Co-investigator)